Real-life data on safety and efficacy of autologous stem cell transplantation in elderly patients with multiple myeloma

Efficacy and safety of autologous hematopoietic cell transplantation in elderly patients with multiple myeloma: a retrospective national multi-site cohort study

(2016) Yael C Cohen et al.   ANNALS OF HEMATOLOGY

Autologous stem cell transplant for multiple myeloma patients 70 years or older

(2016) E Muchtar et al.   BONE MARROW TRANSPLANTATION

Survival of elderly patients with multiple myeloma—Effect of upfront autologous stem cell transplantation

(2016) Maximilian Merz et al.   EUROPEAN JOURNAL OF CANCER

Autotransplant with and without induction chemotherapy in older multiple myeloma patients: long-term outcome of a randomized trial

(2016) Christian Straka et al.   HAEMATOLOGICA

Upfront autologous stem cell transplantation for newly diagnosed elderly multiple myeloma patients: a prospective multicenter study

(2016) Laurent Garderet et al.   HAEMATOLOGICA

International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma

(2016) Shaji Kumar et al.   LANCET ONCOLOGY

Autotransplant with and without induction chemotherapy in older multiple myeloma patients: long-term outcome of a randomized trial

(2016) Christian Straka et al.   HAEMATOLOGICA

Upfront autologous stem cell transplantation for newly diagnosed elderly multiple myeloma patients: a prospective multicenter study

(2016) Laurent Garderet et al.   HAEMATOLOGICA

High-dose therapy and autologous stem cell transplant in older adults with multiple myeloma

(2015) T M Wildes et al.   BONE MARROW TRANSPLANTATION

Survival of Multiple Myeloma Patients Aged 65-70 Years in the Era of Novel Agents and Autologous Stem Cell Transplantation

(2014) Shuji Ozaki et al.   ACTA HAEMATOLOGICA

Older Patients with Myeloma Derive Similar Benefit from Autologous Transplantation

(2014) Manish Sharma et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Trends in autologous hematopoietic cell transplantation for multiple myeloma in Europe: increased use and improved outcomes in elderly patients in recent years

(2014) H W Auner et al.   BONE MARROW TRANSPLANTATION

International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma

(2014) S Vincent Rajkumar et al.   LANCET ONCOLOGY

Autologous Stem Cell Transplantation in Elderly Patients with Multiple Myeloma: Past, Present, and Future

(2014) Shuji Ozaki et al.   Biomed Research International

Autologous stem cell transplantation for elderly patients with newly diagnosed multiple myeloma in the era of novel agents

(2013) M. Merz et al.   ANNALS OF ONCOLOGY

Trends in Utilization and Outcomes of Autologous Transplantation as Early Therapy for Multiple Myeloma

(2013) Luciano J. Costa et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients

(2013) S K Kumar et al.   LEUKEMIA

Management of Newly Diagnosed Symptomatic Multiple Myeloma: Updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Guidelines 2013

(2013) Joseph R. Mikhael et al.   MAYO CLINIC PROCEEDINGS

Feasibility of autologous hematopoietic stem cell transplant in patients aged ≥70 years with multiple myeloma

(2011) Qaiser Bashir et al.   LEUKEMIA & LYMPHOMA

Patterns of Multiple Myeloma During the Past 5 Decades: Stable Incidence Rates for All Age Groups in the Population but Rapidly Changing Age Distribution in the Clinic

(2010) Ingemar Turesson et al.   MAYO CLINIC PROCEEDINGS

Autologous stem cell transplantation in patients of 70 years and older with multiple myeloma: Results from a matched pair analysis

(2008) Shaji K. Kumar et al.   AMERICAN JOURNAL OF HEMATOLOGY